Penserra Capital Management LLC Harpoon Therapeutics, Inc. Transaction History

Penserra Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$5.69 - $7.83 $4,239 - $5,833	-745 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$7.88 - $14.0 $39 - $70	5 Added 0.68%	745 $5,000
Q2 2021 Aug 12, 2021	BUY	$13.81 - $23.25 $138 - $232	10 Added 1.37%	740 $10,000
Q1 2021 May 13, 2021	BUY	$17.65 - $24.16 $2,382 - $3,261	135 Added 22.69%	730 $15,000
Q4 2020 Feb 12, 2021	BUY	$12.83 - $17.84 $7,633 - $10,614	595 New	595 $9,000

353K

Ticker HARP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,106,800
Description
Harpoon Therapeutics, Inc., a clinical-stage immunotherapy company, engages in the development of a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases in the United States. The company develops tri-specific T cell activating construct (TriTAC) product candi...

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Penserra Capital Management LLC with notifications on news.